Bumper Offer - Urjas oil Just @ Rs. 1
Tsart 40 Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Heart Failure, High BP. Secondary and off-label uses of Tsart 40 Tablet have also been mentioned below.
The optimal dosage of Tsart 40 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Common side effects of Tsart 40 Tablet include Dizziness, Nausea or vomiting, Back Pain. Besides the aforementioned side effects, there are other adverse effects of Tsart 40 Tablet as well, which are listed below. These side effects of Tsart 40 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Tsart 40 Tablet's effect is Severe during pregnancy and Mild for lactating mothers. Further, the section on Tsart 40 Tablet related warnings talks about Tsart 40 Tablet's effects on the liver, heart and kidney.
Tsart 40 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Tsart 40 Tablet in conditions like Angioedema, Hyperkalemia, Drug Allergy.
Drug reaction of Tsart 40 Tablet with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Tsart 40 Tablet is considered not safe while driving, and is not addictive.
Tsart 40 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Tsart 40 Tablet is used -
Severe
Mild
Common
Is the use of Tsart 40 Tablet safe for pregnant women?
Tsart should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Tsart 40 Tablet safe during breastfeeding?
Tsart has been seen to have minimal side effects on breastfeeding women.
What is the effect of Tsart 40 Tablet on the Kidneys?
Tsart is not harmful for kidneys.
What is the effect of Tsart 40 Tablet on the Liver?
Tsart is rarely harmful for the liver.
What is the effect of Tsart 40 Tablet on the Heart?
Side effects of Tsart rarely affect the heart.
Tsart 40 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Tsart 40 Tablet unless your doctor advises you to do so -
Is this Tsart 40 Tablet habit forming or addictive?
Forming a habit of Tsart 40 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Tsart 40 Tablet, you should not drive or work on any heavy machine, as Tsart 40 Tablet can make you drowsy.
Is it safe?
Tsart 40 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Tsart 40 Tablet in mental disorders is not effective.
Interaction between Food and Tsart 40 Tablet
When consumed with certain foods, Tsart 40 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Tsart 40 Tablet
Taking alcohol with Tsart 40 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
